GlaxoSmithKline Pharmaceuticals
₹1,866.95
-21.2 (-1.12%)
- Advice
- Hold
19 April, 2024 12:07 BSE: 500660
NSE: GLAXOISIN: INE159A01016
Start SIP in GlaxoSmithKline Pharmaceuticals
Start SIPGlaxoSmithKline Pharmaceuticals Performance
Day Range
- Low 1,854
- High 1,878
52 Week Range
- Low 1,227
- High 2,524
- Open Price1,878
- Previous Close1,888
- Volume15982
GlaxoSmithKline Pharmaceuticals Financials
Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Oper Rev Qtr Cr | 805 | 953 | 738 | 782 |
Operating Expenses Qtr Cr | 587 | 667 | 597 | 615 |
Operating Profit Qtr Cr | 218 | 287 | 141 | 167 |
Depreciation Qtr Cr | 17 | 18 | 16 | 17 |
Interest Qtr Cr | 0 | 0 | 0 | 1 |
Tax Qtr Cr | 20 | 81 | 48 | 56 |
Net Profit Qtr Cr | 45 | 216 | 131 | 131 |
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,866.95
-21.2 (-1.12%)
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹1,943.85
- 50 Day
- ₹2,005.19
- 100 Day
- ₹1,957.78
- 200 Day
- ₹1,809.96
- 20 Day
- ₹1,936.11
- 50 Day
- ₹2,086.77
- 100 Day
- ₹2,016.45
- 200 Day
- ₹1,739.39
GlaxoSmithKline Pharmaceuticals Resistance and Support
PIVOT
₹1,894.45
Resistance | |
---|---|
First Resistance | 1,916.65 |
Second Resistance | 1,945.15 |
Third Resistance | 1,967.35 |
RSI | 37.25 |
MFI | 32.25 |
MACD Single Line | -49.16 |
MACD | -46.28 |
Support | |
---|---|
First Resistance | 1,865.95 |
Second Resistance | 1,843.75 |
Third Resistance | 1,815.25 |
GlaxoSmithKline Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 93,250 | 5,081,193 | 54.49 |
Week | 128,812 | 7,529,061 | 58.45 |
1 Month | 141,503 | 8,843,910 | 62.5 |
6 Month | 225,151 | 13,169,076 | 58.49 |
GlaxoSmithKline Pharmaceuticals Result Highlights
GlaxoSmithKline Pharmaceuticals Synopsis
NSE-Medical-Diversified
Glaxosmithkline Phar is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3216.34 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2023. GlaxoSmithKline Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151.Market Cap | 31,627 |
Sales | 3,279 |
Shares in Float | 4.24 |
No of funds | 261 |
Yield | 1.69 |
Book Value | 18.25 |
U/D Vol ratio | 0.5 |
LTDebt / Equity | |
Alpha | 0.09 |
Beta | 0.72 |
GlaxoSmithKline Pharmaceuticals
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 75% | 75% | 75% | 75% |
Mutual Funds | 4.51% | 4.5% | 4.81% | 4.25% |
Insurance Companies | 3.25% | 4.02% | 5.15% | 5.97% |
Foreign Portfolio Investors | 3.48% | 2.93% | 2.5% | 2.41% |
Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
Individual Investors | 11.27% | 11.08% | 10.62% | 10.57% |
Others | 2.48% | 2.46% | 1.91% | 1.79% |
GlaxoSmithKline Pharmaceuticals Management
Name | Designation |
---|---|
Ms. R S Karnad | Chairperson |
Mr. B Akshikar | Managing Director |
Dr.(Ms.) S Maheshwari | Director |
Mr. S Williams | Director |
Mr. P V Bhide | Director |
Mr. A N Roy | Director |
Mr. D Sundaram | Director |
Mr. M Anand | Director |
Mr. J Chandy | Director |
GlaxoSmithKline Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
GlaxoSmithKline Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-02-12 | Quarterly Results | |
2023-11-09 | Quarterly Results | |
2023-07-26 | Quarterly Results | |
2023-05-17 | Audited Results & Final Dividend | |
2023-02-07 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-06-30 | FINAL | Rs.32.00 per share(320%)Final Dividend |
2022-07-08 | FINAL | Rs.30.00 per share(300%)Dividend |
2022-07-08 | SPECIAL | Rs.60.00 per share(600%)Special Dividend |
2021-07-20 | FINAL | Rs.30.00 per share(300%)Dividend |
GlaxoSmithKline Pharmaceuticals FAQs
What is Share Price of GlaxoSmithKline Pharmaceuticals ?
GlaxoSmithKline Pharmaceuticals share price is ₹1,866 As on 19 April, 2024 | 11:53
What is the Market Cap of GlaxoSmithKline Pharmaceuticals ?
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹31627.3 Cr As on 19 April, 2024 | 11:53
What is the P/E ratio of GlaxoSmithKline Pharmaceuticals ?
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 59.8 As on 19 April, 2024 | 11:53
What is the PB ratio of GlaxoSmithKline Pharmaceuticals ?
The PB ratio of GlaxoSmithKline Pharmaceuticals is 18.2 As on 19 April, 2024 | 11:53